medigraphic.com
SPANISH

Medimay

ISSN 2520-9078 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 1

<< Back Next >>

Revista de Ciencias Médicas de la Habana 2013; 19 (1)

Primary sclerosing cholangitis associate whith Crohn disease

Bello NM, Rapado VM
Full text How to cite this article

Language: Spanish
References: 10
Page:
PDF size: 55.42 Kb.


Key words:

primary sclerosing cholangitis, Crohn disease, autoimmune, liver transplants.

ABSTRACT

Primary sclerosing cholangitis is a chronic cholestatic liver disease of unknown aetiology characterised by inflammation and fibrosis of the biliary tree. The disease progresses to cirrhosis and liver failure and cholangiocarcinoma develops in many of patients. The mean age at diagnosis is around 40 years and men are affected more often. The disease started is usually insidious and many patients are asymptomatic at diagnosis or have many symptoms. It is often associated with inflammatory bowel disease, especially ulcerative colitis. A case of black female 53 years old patient, who began to present fatigue, abdominal discomfort, pruritus, weight loss, jaundice and choluria. She develops hepatomegaly. The diagnosis of primary sclerosing cholangitis was made by lab tests, immunological tests, retrograde endoscopic cholangiopancreatography and liver biopsy. Liver transplantation remains the only effective therapeutic option for these kinds of patients with end-stage liver disease, although high dose ursodeoxycholic acid may have a beneficial effect.


REFERENCES

  1. Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol [Internet]. 2010 Nov [cited 2011 Jan 20];7(11). Available from: http://www.ncbi.nlm.nih.gov/pubmed/20938459

  2. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM [et al]. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology [Internet]. 2003 Nov [cited 2011 Jan 20];125(5) Available from: http://www.ncbi.nlm.nih.gov/pubmed/14598252

  3. Tischendorf JJ, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: s single center study. Am J Gastroenterol [Internet]. 2007 Jan [cited 2011 Jan 20];102(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/17037993

  4. Rodríguez Fernández R, Buchaca Faxas E, Roselló Silva N, Rodríguez Amador L, Yánez MA, Domínguez Álvarez C. Colangitis esclerosante primaria en paciente con panhipopituitarismo autoinmune: presentación de 1 caso. Rev Cubana Med [Internet]. 2008 Mar [citado 27 Mar 2012];47(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75232008000100010&lng=es .

  5. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM [et al]. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology [Internet]. 2003 Nov [cited 2011 Jan 20];125(5). Available from: http://www.ncbi.nlm.nih.gov/pubmed/14598252

  6. Ananthakrishnan AN, Beaulieu DB, Ulitsky A, Zadvornova Y, Skaros S, Johnson K [et al]. Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? Inflamm Bowel Dis [Internet]. 2010 Mar [cited 2012 Jan 20];16(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/19637332

  7. Gaj P, Habior A, Mikula M, Ostrowski J. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in polish patients. BMC Med Genet [Internet]. 2008 Aug [cited 2012 Jan 20];9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18715515

  8. Emmrich J, Jaster R. Autoimmune diseases in gastroenterology. Curr Pharm Des [Internet]. 2012 [cited 2012 Jan 20];18(29). Available from: http://www.ncbi.nlm.nih.gov/pubmed/22612745

  9. Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology [Internet]. 2001 Oct [cited 2012 Jan 20];121(4). Available from: http://www.ncbi.nlm.nih.gov/pubmed/11606503

  10. Brandsaeter B, Isoniemi H, Broomé U, Olausson M, Bäckman L, Hansen B [et al]. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol [Internet]. 2004 [cited 2012 Jan 20];40(5). Available from: http://www.ncbi.nlm.nih.gov/pubmed/15094230




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista de Ciencias Médicas de la Habana. 2013;19